[Intravenous antibiotic therapy for acute hematogenous osteomyelitis in children: short versus long course]

S Bouchoucha1, K Gafsi, M Trifa

  • 1Service d'orthopédie de l'enfant et de l'adolescent, hôpital d'enfants de Tunis, 1007 Tunis Jabbari, Bab Saadoun, Tunisie. sami.bouchoucha@yahoo.com

Insights

Shortened intravenous antibiotic therapy for acute hematogenous osteomyelitis in children, lasting 7 days, proved as effective as a 14-day protocol. This finding supports optimized treatment durations for pediatric osteomyelitis.

Area of Science:

  • Pediatric Infectious Diseases
  • Orthopedic Surgery
  • Pharmacology

Background:

  • Osteomyelitis is a bone infection requiring prompt antibiotic treatment.
  • The optimal duration of intravenous antibiotic therapy for acute hematogenous osteomyelitis in children is not definitively established.
  • Prolonged antibiotic courses may increase risks and healthcare costs.

Purpose of the Study:

  • To compare the efficacy of a 7-day intravenous antibiotic protocol versus a 14-day protocol for treating acute hematogenous osteomyelitis in children.
  • To evaluate the rate of chronic osteomyelitis development following different treatment durations.

Main Methods:

  • A prospective randomized study involving 53 children diagnosed with acute hematogenous osteomyelitis.
  • Group 1 (G1) received 7 days of intravenous antibiotics.
  • Group 2 (G2) received 14 days of intravenous antibiotics.
  • Treatment effectiveness was assessed by the absence of chronic osteomyelitis signs at follow-up.

Main Results:

  • A total of 53 patients were included (G1=27, G2=26).
  • The mean follow-up period was 11.5 months.
  • No patients in either group exhibited signs of chronic osteomyelitis.
  • Both 7-day and 14-day intravenous antibiotic regimens demonstrated comparable efficacy.

Conclusions:

  • A 7-day intravenous antibiotic treatment course is as effective as a 14-day course for pediatric acute hematogenous osteomyelitis.
  • Shortened antibiotic durations may be a safe and effective option, potentially reducing treatment burden.
  • Further research could explore even shorter durations or oral switch protocols.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...